Steris ( (STE) ) has released its Q1 earnings. Here is a breakdown of the information Steris presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
STERIS plc is a global leader in providing innovative healthcare and life science products and services, focusing on infection prevention to support patient care worldwide. The company operates primarily in the healthcare sector, offering a range of products and services that contribute to creating a healthier and safer world.
In its fiscal 2026 first quarter, STERIS reported a robust financial performance with a 9% increase in total revenue from continuing operations, reaching $1.4 billion. The company’s earnings per share (EPS) from continuing operations rose to $1.79, while adjusted EPS increased to $2.34. The company also updated its fiscal 2026 outlook, reflecting favorable foreign currency impacts.
Key financial highlights include an 8% growth in healthcare revenue, driven by improvements in service, capital equipment, and consumable revenues. The Applied Sterilization Technologies (AST) segment saw a 13% increase in revenue, with significant growth in service and capital equipment revenues. The Life Sciences segment reported a 5% increase in revenue, supported by growth in consumable and service revenues. Additionally, STERIS reported a substantial increase in free cash flow, reaching $326.5 million, up from $195.7 million in the previous year.
The company announced changes to its Board of Directors, with the retirement of two members and the election of Louis Shapiro, adding valuable healthcare industry expertise. Looking ahead, STERIS expects revenue growth of 8-9% for fiscal 2026, with adjusted earnings per share remaining in the range of $9.90 to $10.15, despite challenges from tariffs and healthcare benefit costs.
STERIS’s management remains optimistic about the company’s future, anticipating continued revenue growth supported by favorable foreign currency conditions and strategic initiatives. The company is poised to navigate challenges such as tariffs and inflation while maintaining its commitment to innovation and customer satisfaction.